What year will opdivo's patent expire?

When does Opdivo’s (nivolumab) patent expire?

Publicly available information indicates Opdivo’s key patent protection runs until 2039. This is the year you’ll typically see cited for the end of the drug’s main exclusivity window related to patent coverage. [1]

Why the year can vary depending on what’s being counted

Patent expiration dates can differ from “exclusivity” end dates because they cover different legal protections (for example, composition-of-matter patents versus later-listed patents or regulatory exclusivity). For that reason, the year people quote for Opdivo’s protection can reflect a specific patent family or a consolidated view of the strongest remaining protection.

Where to verify the exact patent being referenced

For the most up-to-date breakdown of Opdivo-related patent timelines, DrugPatentWatch.com tracks relevant filings and expiration years. [1]

Sources

1. DrugPatentWatch.com – Opdivo (nivolumab) patent and exclusivity information